Pancreatic cancer is not only the third leading cause of cancer death in the United States, but also a major public health problem in San Diego. Moores Members Andrew Lowy, MD and Shweta Joshi, PhD are leading groundbreaking research, recently funded by a Lustgarten Foundation Clinical Accelerator Initiative grant, to create new pancreatic cancer treatment therapies. One of these treatments already has been approved by the FDA, which means that its use for treating pancreatic cancer can be expedited. In this Q&A, Dr. Andrew Lowy describes the scope, importance, and reach of his research with Dr. Joshi….Continue Reading Charting New Paths in Pancreatic Cancer Treatment: A Q&A with Lustgarten CAI Grant Recipients
Charting New Paths in Pancreatic Cancer Treatment: A Q&A with Lustgarten CAI Grant Recipients
